Skip to Content
Interactive Textbook on Clinical Symptom Research Logo

Home Button

Hot Flashes Study Sections
 Author Bio
Introduction 
Commentator Bio
Protocol Schema
Protocol Background
Protocol Goals
Patient Eligibility
Test Schedule
Stratification Factors
Registration/Randomization
Protocol Treatment
Dosage Modification
Ancillary Treatment
Toxicity Monitoring
Treatment Evaluation
Descriptive Factors
Treatment/Follow-up
Pharmacologic Studies
Drug Information
Statistical Considerations
Pathology Considerations
Currently selected section: Records/Data Collection Procedures
Budget
Appendices

 

Chapter 2B: Development of a Clinical Trial for Hot Flash Protocol: Records and Data Collection Procedures
 

Microphone Image

18.1 On-study materials - None.

18.2 Follow-up materials

18.21 Double blind study

Within two weeks following completion of the double-blind study, submit the following to the Operations Office:

  • Daily Patient Questionnaire (Appendix III).
  • Nurse Work Sheet (Appendix V), updated to contain information collected during the first 9 weeks of study participation.

18.22 Optional continuation study

18.221 The following is to be mailed to the Operations Office within two weeks after the patient goes off study:

18.222 The following is to be mailed to the Operations Office at 6, 12, and 24 months following start of optional continuation study.

18.3 Off-study materials

No further materials are required following submission of materials in Section 18.2.

 


Page 27 of 29